Overview
Elastofibroma dorsi is a rare, benign soft tissue pseudotumor characterized by the slow-growing accumulation of abnormal elastic fibers and fibrous tissue. It typically develops in the subscapular region, between the lower scapula and the chest wall, most commonly on the right side, though bilateral involvement occurs in a significant proportion of cases. The mass is composed of degenerated elastic fibers interspersed with collagen and mature adipose tissue. Elastofibroma dorsi predominantly affects older adults, particularly women over the age of 55, and is thought to arise from reactive mechanical friction between the scapula and the thoracic wall rather than being a true neoplasm. Many patients are asymptomatic, with the mass discovered incidentally on imaging studies such as CT or MRI performed for other reasons. When symptomatic, patients may experience a palpable swelling or mass beneath the scapula, mild to moderate pain, a sensation of heaviness, and occasionally a snapping or clunking sensation during shoulder movement. The condition primarily affects the musculoskeletal and connective tissue systems. Diagnosis is often made clinically and confirmed by characteristic imaging findings, though biopsy may be performed to exclude malignant soft tissue tumors. Treatment is generally conservative for asymptomatic cases, with observation and reassurance being appropriate. For patients who experience significant pain or functional limitation, surgical excision (marginal resection) is the standard treatment and is usually curative, with low recurrence rates. The etiology remains incompletely understood, though repeated mechanical stress and possible genetic predisposition have been proposed as contributing factors. Some familial clustering has been reported, suggesting a possible hereditary component in certain cases.
Sporadic
Usually appears on its own, not inherited from a parent
Late onset
Begins later in life, typically after age 50
FDA & Trial Timeline
1 eventOndokuz Mayıs University
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Elastofibroma dorsi.
1 clinical trialare actively recruiting — trials can provide access to cutting-edge therapies.
View clinical trials →Specialists
View all specialists →No specialists are currently listed for Elastofibroma dorsi.
Treatment Centers
8 centersChildren's Hospital Colorado Rare Disease Program ↗
Children's Hospital Colorado
📍 Aurora, CO
👤 Boston Children's Hospital Rare Disease Program
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDBoston Children's Hospital Rare Disease Program ↗
Boston Children's Hospital
📍 Boston, MA
👤 Boston Children's Hospital Rare Disease Program
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
🏨 Children'sAnn & Robert H. Lurie Children's Hospital Genetics ↗
Lurie Children's Hospital
📍 Chicago, IL
👤 Boston Children's Hospital Rare Disease Program
🏥 NORDCincinnati Children's Hospital Medical Center ↗
Cincinnati Children's
📍 Cincinnati, OH
👤 Boston Children's Hospital Rare Disease Program
🏨 Children'sNationwide Children's Hospital Rare Disease Center ↗
Nationwide Children's Hospital
📍 Columbus, OH
👤 Boston Children's Hospital Rare Disease Program
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
Travel Grants
No travel grants are currently matched to Elastofibroma dorsi.
Community
No community posts yet. Be the first to share your experience with Elastofibroma dorsi.
Start the conversation →Latest news about Elastofibroma dorsi
No recent news articles for Elastofibroma dorsi.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Elastofibroma dorsi
What is Elastofibroma dorsi?
Elastofibroma dorsi is a rare, benign soft tissue pseudotumor characterized by the slow-growing accumulation of abnormal elastic fibers and fibrous tissue. It typically develops in the subscapular region, between the lower scapula and the chest wall, most commonly on the right side, though bilateral involvement occurs in a significant proportion of cases. The mass is composed of degenerated elastic fibers interspersed with collagen and mature adipose tissue. Elastofibroma dorsi predominantly affects older adults, particularly women over the age of 55, and is thought to arise from reactive mech
How is Elastofibroma dorsi inherited?
Elastofibroma dorsi follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Elastofibroma dorsi typically begin?
Typical onset of Elastofibroma dorsi is late onset. Age of onset can vary across affected individuals.
Are there clinical trials for Elastofibroma dorsi?
Yes — 1 recruiting clinical trial is currently listed for Elastofibroma dorsi on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.